Dogecoin Cash, Inc. is a telemedicine platform for medical marijuana recommendations, transitioning to integrate cryptocurrency and expand digital assets.

# Summary of Dogecoin Cash, Inc. (formerly Cannabis Sativa, Inc.)

## Company Overview
Dogecoin Cash, Inc. operates primarily through its subsidiary, PrestoCorp, Inc., which specializes in providing telemedicine services specifically for medical marijuana recommendations. The company is strategically transitioning its business focus towards integrating cryptocurrency capabilities and expanding its digital asset offerings.

## Business Segments

### Telemedicine Services
- **PrestoCorp** (also known as PrestoDoctor) is an online telemedicine platform facilitating user access to medical marijuana recommendations.
- **Customer Base**: Over 100,000 registered users.
- **Physicians**: The platform connects patients with 15+ licensed physicians across various states.
- **Service Availability**: The service is available in states including Arkansas, California, Georgia, Illinois, Iowa, Louisiana, Minnesota, Missouri, Nevada, New York, Ohio, Oklahoma, Pennsylvania, Texas, and West Virginia.

### Brand Development and Product Marketing
- The Company aims to market and license its brands in the cannabis and CBD sectors.
- **Products in Development**: Includes herbal personal care products, CBD-infused items, and branded merchandise.
- **Current Focus**: Developing relationships with manufacturers and distributors to expand their product portfolios.

## Financial Overview (Year Ended December 31, 2024)
- **Revenue**: $802,704, reflecting a 32% decrease from $1,173,830 in 2023.
- **Gross Profit**: $492,084, with a gross margin of 61%.
- **Operating Expenses**: Totaled $1,185,313, down 28% from the previous year.
- **Net Loss**: $1,730,340 was attributed to the company, compared to a net loss of $1,392,223 in 2023.
- **Accumulated Deficit**: $83,816,573 as of December 31, 2024.
- **Cash on Hand**: The Company reported $34,934 in cash.

## Operational Details
- **Employees**: The Company directly has no traditional employees but engages independent contractors, with a total of four independent contractors providing services.
- **Subsidiaries**: In addition to PrestoCorp, the Company owns several inactive subsidiaries including Wild Earth Naturals, Hi Brands International, and others.

## Strategic Initiatives and Future Focus
- **Telemedicine Expansion**: Plans to grow the telemedicine operations into additional states and diversify its service offerings.
- **Digital Asset Integration**: The Company has acquired Dogecoin Cash tokens and is exploring new opportunities in blockchain and digital assets.
- **Market Trends**: The cannabis sector is characterized by increasing competition and regulatory changes, presenting both challenges and opportunities for Dogecoin Cash, Inc.

By aligning its brand identity and business strategy towards the evolving landscapes of telemedicine and digital assets, Dogecoin Cash, Inc. aims to establish a strong footing in the competitive cannabis and cryptocurrency markets.

Cannabis Sativa, Inc. operates in the cannabis industry primarily through its telemedicine subsidiary, PrestoCorp, providing online medical marijuana evaluations across 13 states while facing significant financial challenges.

# Cannabis Sativa, Inc. Overview

**Company Background**
- **Incorporated:** November 2005 (formerly Ultra Sun Corporation)
- **Headquarters:** Mesquite, Nevada
- **Public Trading Symbol:** CBDS on OTCQB Market

## Operations
Cannabis Sativa, Inc. primarily operates in the cannabis industry through its subsidiary, **PrestoCorp, Inc.** (also known as PrestoDoctor), which provides telemedicine services. 

### Telemedicine Services
- **Service Overview:** PrestoDoctor offers an online platform that connects patients with licensed physicians for medical marijuana evaluations.
- **Technology Used:** Secure video conferencing technology for confidential consultations.
- **States Served:** Currently operational in **13 states**, including Oklahoma, California, Nevada, New York, Missouri, Pennsylvania, Illinois, Iowa, Texas, Louisiana, Ohio, Arkansas, and West Virginia. Expansion into additional states is planned.
- **Customer Base:** Over **100,000 registered users** have accessed PrestoDoctor's services.

### Products and Brand Strategy
- **Brand Development:** The company aims to create a portfolio of brands and products related to CBD and cannabis. They are focusing on:
  - **Wild Earth Naturals:** Targets the natural health market through herbal skincare products but is currently inactive.
  - **Hi Brands International:** Previously aimed at CBD-rich products but inactive; potential for future development.
- **Projected Product Offerings for 2024:**
  - Medical and therapeutic lozenges.
  - Herbal healing balms for pain relief.
  - Antioxidant creams and moisturizers.
  - Branded clothing and merchandise.

## Financial Performance
- **Revenue (2023):** $1,173,830, a decrease of **25%** from 2022 revenue of $1,558,752.
- **Gross Profit (2023):** $773,084, with a gross profit margin of **66%**.
- **Net Loss (2023):** $1,392,223, reflecting ongoing operational challenges.
- **Accumulated Deficit (2023):** $82,083,492, indicating long-term financial struggles.

## Employee and Operational Structure
- **Total Employees:** PrestoCorp employs a total of **seven staff members**, including two company officers. 
- **Contractual Relationships:** Cannabis Sativa has independent contractor relationships with four officers and directors, as well as additional outside service providers.

## Capital and Resources
- **Cash Position (End of 2023):** $83,762.
- **Funding Needs:** The company plans to raise additional capital through equity offerings to support its business operations and product development.

## Conclusion
Cannabis Sativa, Inc. operates primarily through its telemedicine subsidiary, PrestoCorp, aiming to expand its market presence and product offerings within the cannabis industry while facing significant financial challenges reflected in its revenue reduction and net losses.

Dogecoin Cash, Inc.

10-K / April 16, 2025

10-K / May 14, 2024

10-K / April 16, 2025

Summary of Dogecoin Cash, Inc. (formerly Cannabis Sativa, Inc.)

Company Overview

Business Segments

Telemedicine Services

Brand Development and Product Marketing

Financial Overview (Year Ended December 31, 2024)

Operational Details

Strategic Initiatives and Future Focus